Pathological analysis of struts coverage after second- and third-generation drug-eluting stents implantation for duration of dual anti-platelets therapy; an autopsy study

被引:0
|
作者
Alhara, K. [1 ]
Torii, S. [1 ]
Nakamura, N. [1 ]
Nakazawa, G. [2 ]
Ikari, Y. [1 ]
机构
[1] Tokai Univ, Sch Med, Hiratsuka, Kanagawa, Japan
[2] Kindai Univ, Osaka, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2057 / 2057
页数:1
相关论文
共 50 条
  • [1] Second- and third-generation drug-eluting coronary stents
    Akin, I.
    Schneider, H.
    Ince, H.
    Kische, S.
    Rehders, T. C.
    Chatterjee, T.
    Nienaber, C. A.
    HERZ, 2011, 36 (03) : 190 - 196
  • [2] Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?
    Gherasie, Flavius-Alexandru
    Valentin, Chioncel
    Busnatu, Stefan-Sebastian
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (05):
  • [3] Duration of dual antiplatelet therapy after implantation of the first-generation and second-generation drug-eluting stents
    Yu, Xianpeng
    Chen, Fang
    He, Jiqiang
    Gao, Yuechun
    Wu, Changyan
    Luo, Yawei
    Zhang, Xiaoling
    Zhang, Yuchen
    Ren, Xuejun
    Lv, Shuzheng
    CORONARY ARTERY DISEASE, 2013, 24 (03) : 217 - 223
  • [4] Characteristics of recurrent in-stent restenosis after second- and third-generation drug-eluting stent implantation
    Shimono, Hirokazu
    Kajiya, Takashi
    Takaoka, Junichiro
    Miyamura, Akihiro
    Inoue, Takafumi
    Kitazono, Kazunari
    Ninomiya, Toshiko
    Atsuchi, Yoshihiko
    Atsuchi, Nobuhiko
    Ohishi, Mitsuru
    CORONARY ARTERY DISEASE, 2021, 32 (01) : 36 - 41
  • [5] Genetic risk model for in-stent restenosis of second- and third-generation drug-eluting stents
    Liu, Yen-Wen
    Huang, Mu-Shiang
    Hsu, Ling-Wei
    Chang, Hsien-Yuan
    Lee, Cheng-Han
    Lee, Chi-Ying
    Chen, Dao-Peng
    Li, Yi-Heng
    Chao, Ting-Hsin
    Su, Pei-Fang
    Shen, Meng-Ru
    Liu, Ping-Yen
    ISCIENCE, 2021, 24 (09)
  • [6] SHORT VERSUS LONG DURATION OF DUAL ANTIPLATELET THERAPY AFTER SECOND GENERATION DRUG-ELUTING STENTS IMPLANTATION IN DIABETICS
    Gangwani, Manesh Kumar
    Aziz, Abeer
    Sagheer, Shazib
    Ahuja, Priyanka
    Lee-Smith, Wade
    Aziz, Muhammad
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 129 - 129
  • [7] Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents.
    Park, Seung-Jung
    Park, Duk-Woo
    Kim, Young-Hak
    Kang, Soo-Jin
    Lee, Seung-Whan
    Lee, Cheol Whan
    Han, Ki-Hoon
    Park, Seong-Wook
    Yun, Sung-Cheol
    Lee, Sang-Gon
    Rha, Seung-Woon
    Seong, In-Whan
    Jeong, Myung-Ho
    Hur, Seung-Ho
    Lee, Nae-Hee
    Yoon, Junghan
    Yang, Joo-Young
    Lee, Bong-Ki
    Choi, Young-Jin
    Chung, Wook-Sung
    Lim, Do-Sun
    Cheong, Sang-Sig
    Kim, Kee-Sik
    Chae, Jei Keon
    Nah, Deuk-Young
    Jeon, Doo-Soo
    Seung, Ki Bae
    Jang, Jae-Sik
    Park, Hun Sik
    Lee, Keun
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (15): : 1374 - 1382
  • [8] Optimizing the Duration of Dual Antiplatelet Therapy After Implantation of Drug-eluting Coronary Stents
    Shen Ying
    Shen Wei-Feng
    中华医学杂志英文版, 2015, 128 (06) : 711 - 713
  • [9] Optimizing the Duration of Dual Antiplatelet Therapy After Implantation of Drug-eluting Coronary Stents
    Shen, Ying
    Shen, Wei-Feng
    CHINESE MEDICAL JOURNAL, 2015, 128 (06) : 711 - 713
  • [10] Is the Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents the Longer the Better?
    Huang, Qing-Yu
    Bista, Madhab
    Yang, Ren-Qiang
    MEDICAL PRINCIPLES AND PRACTICE, 2015, 24 (04) : 398 - 398